Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
Medivir Presents MIV-818 Data at AACR-NCI-EORTC in Boston PR Newswire STOCKHOLM, Oct. 30, 2019 STOCKHOLM, Oct. 30, 2019 /PRNewswire/ -- Medivir...
US National Cancer Institute Initiates Phase I Study of Treatment of Head and Neck Cancer Patients With Medivir's Birinapant and Radiation...
Selective Effect Signal on Liver Cancer Tissue in Phase Ia Study With MIV-818 PR Newswire STOCKHOLM, June 13, 2019 STOCKHOLM, June 13, 2019...
Medivir to Present at the 2019 BIO International Convention PR Newswire STOCKHOLM, June 4, 2019 STOCKHOLM, June 4, 2019 /PRNewswire/ -- Medivir...
New Data From the Phase I Study of Birinapant in Combination With Keytruda® Presented at ASCO PR Newswire STOCKHOLM, June 3, 2019 STOCKHOLM, June...
Medivir to Present at the Redeye Pre-ASCO Seminar on May 28 PR Newswire STOCKHOLM, May 27, 2019 STOCKHOLM, May 27, 2019 /PRNewswire/ -- Medivir...
New Data From the Phase I Study of Birinapant in Combination With Keytruda® Will be Presented at the ASCO 2019 PR Newswire HUDDINGE, Sweden, May...
Positive Data From The Remetinostat Phase II Study in Basal Cell Carcinoma Presented at SID Annual meeting PR Newswire STOCKHOLM, May 13, 2019...
Data From the Remetinostat Phase II Study in Basal Cell Carcinoma Patients to be Presented at the 2019 SID Annual Meeting PR Newswire STOCKHOLM...
Safety and Efficacy Data From the MIV-711 Phase II Open Label Extension Study Presented at the OARSI World Congress PR Newswire STOCKHOLM, May 6...
Medivir AB - Interim Report, January - March 2019 Clinical studies progress according to plan PR Newswire HUDDINGE, Sweden, May 3, 2019 HUDDINGE...
Medivir Appoints New CFO PR Newswire HUDDINGE, Sweden, April 29, 2019 HUDDINGE, Sweden, April 29, 2019 /PRNewswire/ -- Medivir AB (Nasdaq...
Lotta Ferm Appointed as Interim CFO at Medivir PR Newswire HUDDINGE, Sweden, Feb. 18, 2019 HUDDINGE, Sweden, Feb. 18, 2019 /PRNewswire/...
Medivir Ab - Year End Report, January - December 2018 PR Newswire HUDDINGE, Sweden, Feb. 14, 2019 HUDDINGE, Sweden, Feb. 14, 2019 /PRNewswire/...
First Patient With Colorectal Cancer Dosed in the Phase ll Study of Birinapant in Combination With Keytruda® PR Newswire STOCKHOLM, Dec. 21, 2018...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관
광고 없는 경험을 위해 가입하세요
지금 사용해 보세요
광고 유지